Cargando…
Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant
Mesenteric plexiform neurofibroma is a subtype of plexiform neurofibroma that involves the mesentery and causes a variety of gastrointestinal complaints. Plexiform neurofibroma is classically found in patients with neurofibromatosis type 1, although genetic contributions to plexiform neurofibroma pa...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191502/ https://www.ncbi.nlm.nih.gov/pubmed/37205972 http://dx.doi.org/10.1097/PG9.0000000000000098 |
_version_ | 1785043475725549568 |
---|---|
author | Gorbounova, Irina Lenahan, Arthur Wenger, Tara Lynn Rudzinski, Erin Tang, Elizabeth Ren-Yee Smith, Caitlin A. Wendel, Danielle Horslen, Simon Ambartsumyan, Lusine |
author_facet | Gorbounova, Irina Lenahan, Arthur Wenger, Tara Lynn Rudzinski, Erin Tang, Elizabeth Ren-Yee Smith, Caitlin A. Wendel, Danielle Horslen, Simon Ambartsumyan, Lusine |
author_sort | Gorbounova, Irina |
collection | PubMed |
description | Mesenteric plexiform neurofibroma is a subtype of plexiform neurofibroma that involves the mesentery and causes a variety of gastrointestinal complaints. Plexiform neurofibroma is classically found in patients with neurofibromatosis type 1, although genetic contributions to plexiform neurofibroma pathogenesis are heterogeneous. We report the first case of mesenteric plexiform neurofibroma in a patient with a YPEL3 pathogenic variant. This patient presented with growth failure, generalized abdominal pain and chronic diarrhea. She was confirmed to have mesenteric plexiform neurofibroma on histopathology and targeted sequencing on affected tissue confirmed that there were no neurofibromatosis type 1 variants present. Given that this patient’s mesenteric plexiform neurofibroma is associated with YPEL3 dysfunction, she is unlikely to benefit from MEK inhibitors, which are the newly approved treatment for inoperable plexiform neurofibroma in patients with neurofibromatosis type 1. |
format | Online Article Text |
id | pubmed-10191502 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101915022023-05-18 Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant Gorbounova, Irina Lenahan, Arthur Wenger, Tara Lynn Rudzinski, Erin Tang, Elizabeth Ren-Yee Smith, Caitlin A. Wendel, Danielle Horslen, Simon Ambartsumyan, Lusine JPGN Rep Case Report Mesenteric plexiform neurofibroma is a subtype of plexiform neurofibroma that involves the mesentery and causes a variety of gastrointestinal complaints. Plexiform neurofibroma is classically found in patients with neurofibromatosis type 1, although genetic contributions to plexiform neurofibroma pathogenesis are heterogeneous. We report the first case of mesenteric plexiform neurofibroma in a patient with a YPEL3 pathogenic variant. This patient presented with growth failure, generalized abdominal pain and chronic diarrhea. She was confirmed to have mesenteric plexiform neurofibroma on histopathology and targeted sequencing on affected tissue confirmed that there were no neurofibromatosis type 1 variants present. Given that this patient’s mesenteric plexiform neurofibroma is associated with YPEL3 dysfunction, she is unlikely to benefit from MEK inhibitors, which are the newly approved treatment for inoperable plexiform neurofibroma in patients with neurofibromatosis type 1. Lippincott Williams & Wilkins, Inc. 2021-07-12 /pmc/articles/PMC10191502/ /pubmed/37205972 http://dx.doi.org/10.1097/PG9.0000000000000098 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer on behalf of European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Gorbounova, Irina Lenahan, Arthur Wenger, Tara Lynn Rudzinski, Erin Tang, Elizabeth Ren-Yee Smith, Caitlin A. Wendel, Danielle Horslen, Simon Ambartsumyan, Lusine Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant |
title | Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant |
title_full | Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant |
title_fullStr | Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant |
title_full_unstemmed | Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant |
title_short | Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant |
title_sort | mesenteric plexiform neurofibroma as a cause of weight loss and chronic diarrhea in a patient with ypel3 variant |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191502/ https://www.ncbi.nlm.nih.gov/pubmed/37205972 http://dx.doi.org/10.1097/PG9.0000000000000098 |
work_keys_str_mv | AT gorbounovairina mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant AT lenahanarthur mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant AT wengertaralynn mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant AT rudzinskierin mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant AT tangelizabethrenyee mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant AT smithcaitlina mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant AT wendeldanielle mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant AT horslensimon mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant AT ambartsumyanlusine mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant |